 |
Previous Article | Next Article 
Volume 17, Number 15,
Issue of August 1, 1997
pp. 5993-6000
Copyright ©1997 Society for Neuroscience
rG 1: A Psychostimulant-Regulated Gene Essential
for Establishing Cocaine Sensitization
Received Feb. 7, 1997; revised May 15, 1997; accepted May 20, 1997.
Xiao-Bing Wang1,
Masahiko Funada1,
Yasuo Imai1,
Randal S. Revay1,
Hiroshi Ujike1,
David J. Vandenbergh1, and
George R. Uhl1, 2
1 Molecular Neurobiology Branch, Intramural Research
Program, National Institute on Drug Abuse, and
2 Departments of Neurology and Neuroscience, Johns Hopkins
University School of Medicine, Baltimore, Maryland 21224
Repeated doses of cocaine or amphetamine lead to long-lasting
behavioral manifestations that include enhanced responses termed sensitization. Although biochemical mechanisms that underlie these manifestations currently remain largely unknown, new protein synthesis has been implicated in several of these neuroadaptive processes. To
seek candidate biochemical mechanisms for these drug-induced neuroplastic behavioral responses, we have used an approach termed subtracted differential display (SDD) to identify genes whose expression is regulated by these psychostimulants. rG 1
is one of the SDD products that encodes a rat G-protein subunit.
rG 1 expression is upregulated by cocaine or amphetamine
treatments in neurons of the nucleus accumbens shell region, a major
center for psychostimulant effects in locomotor control and behavioral reward. Antisense oligonucleotide treatments that attenuate
rG 1 expression in regions including the nucleus
accumbens abolish the development of behavioral sensitization when they
are administrated during the repeated cocaine exposures that establish
sensitization. These treatments fail to alter acute behavioral
responses to cocaine, and they do not block the expression of cocaine
sensitization when it is established before oligonucleotide
administrations. Full, regulated rG 1 expression is a
biochemical component essential to the establishment of a key
consequence of repeated cocaine administrations, sensitization.
Key words:
PCR differential display;
amphetamine;
cocaine;
G-protein;
sensitization;
gene regulation;
addiction
This article has been cited by other articles:

|
 |

|
 |
 
M. Niwa, A. Nitta, H. Mizoguchi, Y. Ito, Y. Noda, T. Nagai, and T. Nabeshima
A Novel Molecule "Shati" Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference
J. Neurosci.,
July 11, 2007;
27(28):
7604 - 7615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Ahmed, R. Lutjens, L. D. van der Stap, D. Lekic, V. Romano-Spica, M. Morales, G. F. Koob, V. Repunte-Canonigo, and P. P. Sanna
Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction
PNAS,
August 9, 2005;
102(32):
11533 - 11538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhu, T. Hon, W. Ye, and L. Zhang
Heme Deficiency Interferes with the Ras-Mitogen-activated Protein Kinase Signaling Pathway and Expression of a Subset of Neuronal Genes
Cell Growth Differ.,
September 1, 2002;
13(9):
431 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-R. Liu, P.-W. Zhang, Q. Zhen, D. Walther, X.-B. Wang, and G. R. Uhl
KEPI, a PKC-dependent Protein Phosphatase 1 Inhibitor Regulated by Morphine
J. Biol. Chem.,
April 5, 2002;
277(15):
13312 - 13320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Neugebauer, F. Zinebi, R. Russell, J. P. Gallagher, and P. Shinnick-Gallagher
Cocaine and Kindling Alter the Sensitivity of Group II and III Metabotropic Glutamate Receptors in the Central Amygdala
J Neurophysiol,
August 1, 2000;
84(2):
759 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Nestler and G. K. Aghajanian
Molecular and Cellular Basis of Addiction
Science,
October 3, 1997;
278(5335):
58 - 63.
[Abstract]
[Full Text]
|
 |
|
|

|